With 45,000 attendees from 150 countries, CPhI is one of the biggest pharma events of the world.

CPHI-2019

Solvay will feature its pharmaceutical solutions portfolio as an historical reliable suppliers of the Pharma industry. The Group is able to meet the needs of these highly-demanding players worldwide and specifically in growth regions.

Solvay Special Chem is a leading manufacturer of fluorinated specialties such as Organic Fluorinated Intermediates comprising the CF3 products:

Solvay Soda Ash & Derivatives is offering pharmaceutical ingredients meeting high quality standards.

Solvay Technology Solutions will present its portfolio of phosphorus derivatives, which find utility in many applications and chemistries. Our life sciences portfolio includes CYTOP®, CYPHOS® and RhodaPhos® products manufactured for the synthesis of high-purity oligonucleotides, prodrugs and ligands for catalytic transformations such as hydrogenation, carbonylation and coupling reactions. Solvay has a long history of transitioning customer ideas from the laboratory to industrial production and offers a consistent supply source.

Solvay Novecare is a global partner for pharmaceutical companies as the worldwide leader of Docusates and offering solubilizing, wetting, dispersing, emulsifying agents and tablet manufacturing aids, all manufactured to the highest quality standards under current good manufacturing practices (cGMP).

Solvay Novecare pharmaceutical excipients and API portfolio includes Docusates, PEGs, Poloxamers, Polysorbates and other specialty surfactants.